Hypertension Management by Pharmacist Interventions

By Danélia Botes

November 10, 2023

The Rising Challenge of Hypertension

Hypertension management, a significant risk factor for cardiovascular and kidney diseases, is a leading cause of preventable death and disability globally. With more than 100 million people affected in the US alone, the healthcare costs associated with hypertension surpassed $130 billion between 2003 and 2014. Despite the availability of affordable medications and lifestyle interventions, blood pressure control rates continue to decline.

Pharmacist Interventions: A New Approach to Hypertension Management

Recent research suggests an innovative solution: pharmacist-led interventions. Pharmacists, who often see patients more frequently than physicians, are well-positioned to screen and manage hypertension. Numerous clinical trials have demonstrated improved hypertension outcomes through pharmacist-led case-finding and prescribing interventions.


A cost-effectiveness analysis of implementing pharmacist prescribing for hypertension management in the US has yielded promising results. The pharmacist intervention was associated with 2100 fewer cases of cardiovascular disease and 8 fewer cases of kidney disease per 10,000 patients. Furthermore, it resulted in overall cost savings of $10,162 per person.

Reference url

Recent Posts

Cutaneous Malignant Melanoma Treatment
        

Forecasting Innovations in Cutaneous Malignant Melanoma Treatment in Sweden

“Shaping Melanoma Care: Insights for UV Safety Month”

🌟 Exciting Insights! Learn how system dynamics modelling shapes the future of cutaneous malignant melanoma care during UV Safety Month. Discover key strategies for better healthcare planning and patient outcomes. #SyenzaNews #UVSafetyMonth #HealthcarePlanning #MelanomaCare #PreventiveInterventions 🏥

skin cancer primary prevention
           

Enhancing Skin Cancer Prevention in a Primary Care Setting

🌞 Discover the latest strategies in skin cancer primary prevention! From innovative risk assessment tools to new technologies, learn how primary care can play a pivotal role in reducing skin cancer rates.
🩺👩‍⚕️👨‍⚕️ #SyenzaNews #Healthcare #SkinCancerPrevention #PrimaryCare #Innovation

Valvular heart disease in Saudi Arabia
           

Addressing Valvular Heart Disease in Saudi Arabia

#SyenzaNews 🚀 Valvular heart disease (VHD) is a growing concern in Saudi Arabia, especially among the ageing population.
Discover the current challenges and actionable recommendations to enhance VHD care.

Let’s work together to improve awareness, detection, and treatment! #Healthcare #Cardiology #SaudiArabia #HealthyAging 🌟

When you partner with Syenza, it’s like a Nuclear Fusion.

Our expertise are combined with yours, and we contribute clinical expertise and advanced degrees in health policy, health economics, systems analysis, public finance, business, and project management. You’ll also feel our high-impact global and local perspectives with cultural intelligence.

SPEAK WITH US

CORRESPONDENCE ADDRESS

1950 W. Corporate Way, Suite 95478
Anaheim, CA 92801, USA

JOIN NEWSLETTER




SERVICES

© 2024 Syenza™. All rights reserved.